Our Services

Publications Planning & Medical Writing

High quality medical writing & project management support services

Process Audits

We find out if your processes & policies are achieving the desired results you need

Strategic Communications

Highly experienced at writing strategic communications & publications plans, & providing strategic advice

Medical Education & Training

Training & educational solutions that precisely match your needs & expectations

Health Economics Communications

One of the few agencies in the world with genuine health economics communications expertise

Creative Solutions

Conceptualise your ideas with on-line & off-line design, creative & production work

Evidence-Based Tools & Services

Our evidence-based tools & services help your organisation get ahead of the field

Education & Training Booklets

Education & training booklets that can also be customized for your organisation

Rx Communications...

making accurate, valuable information accessible

A Boutique Medical Communications Agency

Why choose Rx Communications?

  • The longest established and largest medical communications agency specialising in health economics and outcomes communications, publications and training
  • One of the most ethical and compliant medical communications agencies in healthcare today
  • A leader in innovative communications and publications, strategic planning and management
Why choose Rx

Customer Testimonials

Sadly, the confidential nature of our work means that our client testimonials are anonymous, but we still think it’s important for you know what they think of us anyway!

  • Great work! You could provide finally a good comprehensive manuscript full of data despite the difficulties in the interpretation of results and the extra analysis you had to do.

    Medical Director
  • Great job, with the writing, the timelines and reminders to the authors. It’s a real pleasure to work with you and your team.

    Senior Medical Advisor
  • Let me express my special thanks to Josh and Hannah. You guys were great partners, we owe you a lot!

    Medical Director
  • This is a beautifully written paper and provides a prospective that is rarely addressed in the field of AD. Thank you for including me in this work.

    Associate Professor
  • Thanks to the Rx team for the beautifully printed poster/minis and for their help with the shipping. All went smoothly – so I really appreciate your help with the logistics.

    Research Scientist, Health Technology Assessment
  • Many thanks for all your hard work and keeping to timelines. You have been great to work with.

    Senior Medical Advisor

Latest news from the Health Economics & Outcomes World

  • AJMC’s ‘This Week in Managed Care’: CMS...

    The American Journal of Managed Care’s Laura Joszt gave a rundown of current events in its “This Week in Managed Care.” Joszt says the Centers for Medicare and Medicaid Services is […]

  • Challenges Ahead for New Pharma CEOS

    The new chief executive officers for Teva Pharmaceutical Industries (TPI) and Novartis are in for a challenge in the ever-evolving health care landscape, particularly regarding payer and pricing. […]

  • Graphic: 7 Biosimilars OK’d by FDA

    The U.S. Food and Drug Administration to date has approved seven biosimilars, including Zarxio, Inflectra and Erelzi. A rundown on the seven biosimilars can be seen at left. (Graphic courtesy of […]

Health Outcomes Communicator (HOC)

Read more
  • Do Outcome Measures in Pain Trials Hamper Drug Development?

    Chronic pain and other pain disorders are notoriously hard to treat, with approximately 40% of patients reporting insufficient relief from their medication. There is a huge unmet need for safe and effective drugs, referred to as analgesics, designed to treat pain as their primary function.

  • Rx Communications at the 52nd EASD Annual Meeting

    The annual European Association for the Study of Diabetes conference took place on the 12th–16th September 2016 at the ICM Messe Congress Centre in Munich, Germany. Munich is the largest city in German Bavaria and delegates attending the meeting also had the opportunity to enjoy the city’s culture, architecture and beautiful parks, as well as the local hospitality.

  • The New Cancer Drugs Fund Appraisal Process

    Since its launch 5 years ago, the Cancer Drugs Fund (CDF) is estimated to have helped over 95,000 patients gain access to lifesaving drugs and technologies. The CDF began as a temporary collaboration, between NICE and NHS England, that was extended in 2014 and due to end March 2016.

  • A Newcomer’s Viewpoint of the Diabetes UK Conference

    The Diabetes UK Professional Conference (DUK) is a major event, highly anticipated by its delegates. It has been running for over 20 years and for 2017 (April) it will take place in the Manchester Central Convention Complex.

  • mHealth: Current Opportunities and Challenges

    Services in many aspects of life are becoming virtual; shops, utility bills and even the faithful paperback book have now become digitised, with an increasing number of us adopting these new formats due to the convenience and cost savings they offer. In the last decade, healthcare spending in the OECD has increased from an average…

HOC Sign-Up

Get our Health Outcomes Communicator direct to your inbox – sign-up now!

Please note: we will not pass your details on to any third-parties